Search

Author/Creator Adjei, Alex A

2. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study. Issue 8 (August 2019)

Authors:
Luo, Yung-Hung; Luo, Lei; Wampfler, Jason A; Wang, Yi; Liu, Dan; Chen, Yuh-Min; Adjei, Alex A; Midthun, David E; Yang, Ping
Journal:
Lancet oncology
Issue:
Volume 20:Issue 8(2019)
Page Start:
1098
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial. Issue 12 (December 2017)

Authors:
Wakelee, Heather A; Dahlberg, Suzanne E; Keller, Steven M; Tester, William J; Gandara, David R; Graziano, Stephen L; Adjei, Alex A; Leighl, Natasha B; Aisner, Seena C; Rothman, Jan M; Patel, Jyoti D; Sborov, Mark D; McDermott, Sean R; Perez-Soler, Roman; Traynor, Anne M; Butts, Charles; Evans, Tr...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 12(2017:Dec.)
Page Start:
1610
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial. Issue 4 (12th April 2022)

Authors:
Aggarwal, Charu; Prawira, Amy; Antonia, Scott; Rahma, Osama; Tolcher, Anthony; Cohen, Roger B; Lou, Yanyan; Hauke, Ralph; Vogelzang, Nicholas; P Zandberg, Dan; Kalebasty, Arash Rezazadeh; Atkinson, Victoria; Adjei, Alex A; Seetharam, Mahesh; Birnbaum, Ariel; Weickhardt, Andrew; Ganju, Vinod; Josh...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗